Skip to main content
Premium Trial:

Request an Annual Quote

Aclara to Lose CEO; High Throughput Genomics Gets New CFO; and Others

NEW YORK, Oct. 16 - Aclara today said that President and CEO Joseph Limber will step down on Dec. 1 to "pursue other interests."

 

He will stay on as a member of the board and help the company find a replacement, Aclara said. Edward Hurwitz, a board member, will serve as executive director and lead the executive team while Aclara looks for a new head.

 

The company also said it has promoted VP of advanced technologies Sharat Singh to senior vice president of it eTag assay-technology division; named senior VP of R&D Dennis Harris as senior vice president of systems integration and business development; and promoted marketing director Dawn Madden to vice president of marketing.

 


 

Protedyne today said it has appointed Catherine Williams as executive vice president of sales and marketing.

 

Williams comes to Protedyne from PerkinElmer Instruments, where she was vice president of sales and services.

 


 

Gene-IT today said it has appointed Richard Resnick vice president of service operations.

 

Resnick, a Whitehead alumni, will oversee Gene-IT's comparative-genomics service business around its core product, Biofacet.

 

He comes to Gene-IT from Mosaic Bioinformatics, which he helped found, and from the Whitehead Institute's Center for Genome Research, where he helped build automation equipment.

 


 

High Throughput Genomics has tapped Kirk Collamer CFO and vice president, the company said yesterday.

 

Collamer comes to the Tucson, Ariz. company from Pointshare, a healthcare-technology provider, where he was CFO executive VP. Collamer, who helped lead Pointshare through an IPO, may also be expected to do the same for HTG. As CEO Bruce Seligmann said, "Kirk has steadily grown entrepreneurial companies, positioning them for long-term financial success. ..."

 


 

Caliper Technologies has promoted three executives, the company said Oct. 9.

 

Anne Kopf-Sill, former senior director of genetic analysis, will be senior vice president of new products and "extend" Caliper's microfluidics research and manage the initial product design and development of LabChip products.

 

Robert Nagle, a research fellow and director of engineering at Caliper, was named vice president of product development. He will oversee all LabChip fabrication R&D, engineering programs, and manage all projects related to the technology through commercialization.

 

Anthony Hendrickson, Caliper's comptroller and chief accounting officer, was named vice president of finance. He will manage Caliper's facilities, the company said.

 


 

Promoted? Changing jobs? GenomeWeb wants to know. E-mail Kat McGowan at [email protected] to appear in PEOPLE, a roundup of personnel comings and goings in genomics that runs every Wednesday.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.